NEPHROCARE IPO ANALYSIS
Shares worth $26 billion can soon hit market as IPO lock-ins endApproximately $26 billion in shares from 71 recently listed companies will become available for sale as IPO lock-ins expire between June 17...
Nephrocare Health IPO Day 2: GMP improves but subscription demand remains weak. Should you apply?Nephrocare Health Services’ Rs 871-crore IPO has seen a muted initial response despite an improving grey market premium. Strong financial g...
Can Nephrocare’s IPO prove a rewarding bet for long-term investors?Nephrocare Health Services, a leading dialysis provider, is set to raise funds through an IPO. The company aims to repay debt and invest in...
- Load More